Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Grissinger Michael | Director | 3 | $0 | $0 | 2020-06-03 |
| Steinberg David Adam | Director | 2 | $0 | $0 | 2020-06-03 |
| Sullivan Lynne Marie | Director | 2 | $0 | $0 | 2020-06-03 |
| FONTEYNE PAUL R. | Director | 2 | $0 | $0 | 2020-06-03 |
| Chodakewitz Jeffrey | Director | 3 | $0 | $0 | 2020-06-03 |
| SILVERSTEIN JONATHAN | Director, 10% Owner | 7 | $8.00M | $0 | 2020-06-03 |
| PureTech Health LLC | 10% Owner | 9 | $3.50M | $9.29M | 2019-12-18 |
| Klickstein Lloyd | Chief Scientific Officer | 3 | $0 | $0 | 2019-12-06 |
| Mannick Joan | Chief Medical Officer | 5 | $0 | $0 | 2019-12-06 |
| Schor Chen | See Remarks | 12 | $53.5K | $0 | 2019-12-06 |
| MCCABE JOHN J | Vice President, Finance | 4 | $0 | $0 | 2019-12-06 |
| Manning Meredith | Chief Commercial Officer | 2 | $0 | $0 | 2019-02-27 |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | 5 | $8.00M | $0 | 2018-01-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Chodakewitz Jeffrey | Director | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| Steinberg David Adam | Director | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| Sullivan Lynne Marie | Director | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| SILVERSTEIN JONATHAN | Director | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| Grissinger Michael | Director | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| PureTech Health LLC | 10% Owner | S Sale | 2019-12-18 | 2019-12-19 | 6,161,531 | $1.20 | $7.39M | 2,119,696 | SEC↗ |
| PureTech Health LLC | 10% Owner | S Sale | 2019-12-13 | 2019-12-17 | 205,763 | $1.24 | $255.1K | 8,281,227 | SEC↗ |
| PureTech Health LLC | 10% Owner | S Sale | 2019-12-12 | 2019-12-12 | 385,884 | $1.25 | $482.4K | 8,486,990 | SEC↗ |
| PureTech Health LLC | 10% Owner | S Sale | 2019-12-11 | 2019-12-12 | 59,921 | $1.25 | $74.9K | 8,872,874 | SEC↗ |
| PureTech Health LLC | 10% Owner | S Sale | 2019-12-10 | 2019-12-12 | 336,561 | $1.26 | $424.1K | 8,932,795 | SEC↗ |
| Schor Chen | President and CEO | A Award deriv | 2019-12-06 | 2019-12-06 | 258,000 | — | $0 | 258,000 | SEC↗ |
| Klickstein Lloyd | Chief Scientific Officer | A Award deriv | 2019-12-06 | 2019-12-06 | 88,667 | — | $0 | 88,667 | SEC↗ |
| MCCABE JOHN J | Vice President, Finance | A Award deriv | 2019-12-06 | 2019-12-06 | 16,400 | — | $0 | 16,400 | SEC↗ |
| Mannick Joan | Chief Medical Officer | A Award deriv | 2019-12-06 | 2019-12-06 | 88,667 | — | $0 | 88,667 | SEC↗ |
| Schor Chen | President and CEO | A Award | 2019-12-06 | 2019-12-06 | 344,000 | — | $0 | 669,000 | SEC↗ |
| Klickstein Lloyd | Chief Scientific Officer | A Award | 2019-12-06 | 2019-12-06 | 118,222 | — | $0 | 118,222 | SEC↗ |
| MCCABE JOHN J | Vice President, Finance | A Award | 2019-12-06 | 2019-12-06 | 12,867 | — | $0 | 12,867 | SEC↗ |
| Mannick Joan | Chief Medical Officer | A Award | 2019-12-06 | 2019-12-06 | 118,222 | — | $0 | 1,404,585 | SEC↗ |
| PureTech Health LLC | 10% Owner | S Sale | 2019-11-15 | 2019-11-19 | 531,040 | $1.25 | $663.8K | 9,269,356 | SEC↗ |
| Klickstein Lloyd | Chief Scientific Officer | A Award deriv | 2019-05-13 | 2019-05-15 | 295,000 | — | $0 | 295,000 | SEC↗ |
| Steinberg David Adam | Director | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| Chodakewitz Jeffrey | Director | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| Grissinger Michael | Director | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| SILVERSTEIN JONATHAN | Director | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| Sullivan Lynne Marie | Director | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| MCCABE JOHN J | Vice President, Finance | A Award deriv | 2019-02-27 | 2019-02-28 | 24,600 | — | $0 | 24,600 | SEC↗ |
| Manning Meredith | Chief Commercial Officer | A Award deriv | 2019-02-27 | 2019-02-28 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Schor Chen | President and CEO | A Award deriv | 2019-02-27 | 2019-02-28 | 214,000 | — | $0 | 214,000 | SEC↗ |
| Mannick Joan | Chief Medical Officer | A Award deriv | 2019-02-27 | 2019-02-28 | 93,000 | — | $0 | 93,000 | SEC↗ |
| Grissinger Michael | Director | A Award deriv | 2018-11-05 | 2018-11-06 | 28,828 | — | $0 | 28,828 | SEC↗ |
| Schor Chen | See Remarks | G Gift | 2018-11-05 | 2018-12-17 | 6,000 | — | $0 | 325,000 | SEC↗ |
| Mannick Joan | Chief Medical Officer | G Gift | 2018-10-26 | 2018-12-17 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Mannick Joan | Chief Medical Officer | G Gift | 2018-10-26 | 2018-12-17 | 600,000 | — | $0 | 1,286,363 | SEC↗ |
| Schor Chen | See Remarks | G Gift | 2018-10-15 | 2018-12-17 | 25,000 | — | $0 | 943,000 | SEC↗ |
| Schor Chen | See Remarks | G Gift | 2018-10-15 | 2018-12-17 | 643,000 | — | $0 | 943,000 | SEC↗ |
| Schor Chen | See Remarks | G Gift | 2018-10-15 | 2018-12-17 | 593,363 | — | $0 | 356,000 | SEC↗ |
| Schor Chen | See Remarks | G Gift | 2018-10-15 | 2018-12-17 | 25,000 | — | $0 | 331,000 | SEC↗ |
| Manning Meredith | Chief Commercial Officer | A Award deriv | 2018-09-17 | 2018-09-18 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Chodakewitz Jeffrey | Director | A Award deriv | 2018-08-14 | 2018-08-15 | 28,828 | — | $0 | 28,828 | SEC↗ |
| Schor Chen | See Remarks | G Gift | 2018-07-06 | 2018-12-17 | 943,000 | — | $0 | 949,363 | SEC↗ |
| Schor Chen | President and CEO | P Buy | 2018-04-16 | 2018-04-17 | 2,000 | $8.95 | $17.9K | 1,892,363 | SEC↗ |
| Schor Chen | President and CEO | P Buy | 2018-04-11 | 2018-04-12 | 2,000 | $9.36 | $18.7K | 1,890,363 | SEC↗ |
| Schor Chen | President and CEO | P Buy | 2018-04-10 | 2018-04-11 | 2,000 | $8.46 | $16.9K | 1,888,363 | SEC↗ |
| MCCABE JOHN J | Vice President, Finance | A Award deriv | 2018-03-13 | 2018-03-14 | 4,603 | — | $0 | 4,603 | SEC↗ |
| PureTech Health LLC | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 7,680,700 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,871,569 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 2,425,482 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 2,425,482 | — | $0 | 0 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,871,569 | — | $0 | 0 | SEC↗ |
| PureTech Health LLC | 10% Owner | P Buy | 2018-01-30 | 2018-01-30 | 233,333 | $15.00 | $3.50M | 9,800,396 | SEC↗ |
| PureTech Health LLC | 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 7,680,700 | — | $0 | 9,567,063 | SEC↗ |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | P Buy | 2018-01-30 | 2018-01-30 | 533,333 | $15.00 | $8.00M | 4,830,387 | SEC↗ |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 1,871,569 | — | $0 | 4,297,054 | SEC↗ |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 2,425,485 | — | $0 | 2,425,485 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | P Buy | 2018-01-30 | 2018-01-30 | 533,333 | $15.00 | $8.00M | 4,830,387 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 1,871,569 | — | $0 | 4,297,054 | SEC↗ |
| SILVERSTEIN JONATHAN | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 2,425,485 | — | $0 | 2,425,485 | SEC↗ |